Description: XWELL, Inc. (Nasdaq: XWEL) is a leading global health and wellness holding company operating four brands: XpresCheck®, XpresSpa®, Treat™ and HyperPointe. XpresSpa is a leading airport retailer of wellness services and related products, with 26 locations in 13 airports globally. Treat is a travel health and wellness brand, the first fully integrated in-airport spa and wellness concept, providing medical services, state-of-the-art testing, and a holistic approach to physical and mental well-being at three domestic airport locations. XpresCheck is a leading provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting biosurveillance monitoring in its airport locations to identify existing and new SARS-CoV-2 variants. HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.
Home Page: www.xwell.com
XWEL Technical Analysis
254 West 31st Street
New York,
NY
10001
United States
Phone:
(212)-750-9595
Officers
| Name | Title |
|---|---|
| Mr. Ezra T. Ernst | President & CEO |
| Ms. Suzanne Scrabis | Chief Financial Officer |
| Mr. Scott R. Milford | Consultant |
| Mr. Omar A. Haynes | VP of Treasury & Finance |
| Ms. Cara Soffer | Senior VP & General Counsel |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0775 |
| Price-to-Sales TTM: | 0.2066 |
| IPO Date: | 2018-01-05 |
| Fiscal Year End: | December |
| Full Time Employees: | 266 |